GH SecretagoguesLimited ResearchResearch Only

MK-677

Ibutamoren

Not medical advice. For educational and research reference only.

Typical Dose

10–25 mg daily

Route

Oral

Cycle

8–16 week cycles

Storage

Room Temperature

What is MK-677?

Oral ghrelin receptor agonist used in GH-axis research.

Research Indications

Growth Hormone SupportMost Effective

Stimulates natural GH release through pituitary signaling pathways

Body CompositionEffective

Associated with increased lean mass and reduced body fat

Recovery & RepairEffective

Supports tissue repair and recovery from exercise or injury

Sleep QualityModerate

Some protocols show improvements in slow-wave and restorative sleep

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting Dose100 mcgOnce dailySubcutaneous injection
Standard Dose200 mcgTwice dailySubcutaneous injection
Maximum Dose300 mcg3x dailySubcutaneous injection

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

Insulin / IGF-1Monitor
CorticosteroidsCaution
Thyroid HormonesMonitor
BPC-157Compatible
TB-500Compatible
Ipamorelin + CJC-1295 (synergistic combo)Compatible
Somatostatin AnalogsAvoid

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove MK-677 vial from refrigeration and allow to reach room temperature (15–20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial — do not aim directly at the powder

  5. 5

    Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2–3 minutes for full dissolution — solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Improved sleep quality may begin. Mild water retention possible initially.

Week 2–4

Deeper sleep, improved recovery. Appetite may increase slightly.

Week 4–8

Noticeable improvements in body composition, energy, and recovery speed.

Week 8–12

Skin quality improvements, reduced body fat, increased lean mass becoming visible.

Week 12+

Sustained improvements in body composition, strength, and overall vitality.

Side Effects & Safety

  • Water retention and mild bloating, especially early in protocol
  • Increased appetite (particularly with GHRP compounds)
  • Flushing or warmth at injection site
  • Tingling or numbness (carpal tunnel-like symptoms at higher doses)
  • Fatigue or lethargy if dosed at suboptimal times
  • Cortisol and prolactin elevation possible (especially GHRP-6)
  • Rare: Elevated blood glucose — monitor if diabetic or pre-diabetic

FDA Status & Regulatory Info

Research Only

Oral ghrelin receptor agonist used in GH-axis research.

Rx Required: No
503A Ban: No
Telehealth: N/A
Full FDA Status Tracker

Frequently Asked Questions

Research References

External links for education only. We do not control third-party content.

Research purposes only

This page is for educational reference. It is not medical or legal advice. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.